BackOmron Overview

Omron Goodwill

Track Omron's goodwill ($260B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$258.11B
↓ 28.99% YoYΔ $-105.37B vs prior year quarter

Peer trimmed avg / median

Loading

Omron Goodwill History

Loading

Omron vs. peers: Goodwill Comparison

Loading

Omron Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Omron (OMRNY) FAQ

Omron (OMRNY) currently reports a goodwill of $260B as of June 2026. That compares with $360B in the prior-year period — down 29.0% year over year. Use the charts on this page to explore Omron's goodwill history and peer comparisons.

Omron's goodwill decreased from $360B to $260B — a 29.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Omron reported $260B in goodwill as of June 2026. That compares with $360B in the prior-year period — down 29.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $260B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Omron, and consider following OMRNY for alerts when major investors trade the stock.

Omron is classified in the Industrials sector. On goodwill, it currently shows $260B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing OMRNY with unrelated industries.